Literature DB >> 12390968

Response to levodopa in parkinsonian patients with bilateral subthalamic nucleus stimulation.

Elena Moro1, Rianne J A Esselink, Alim Louis Benabid, Pierre Pollak.   

Abstract

The response to levodopa changes over time in Parkinson's disease, probably due to alterations in the dopaminergic system, progression of the disease and pulsatile oral intake of the drug. Bilateral high-frequency stimulation of the subthalamic nucleus (STN) allows a large reduction or the complete cessation of levodopa intake in patients with advanced Parkinson's disease. We studied variation in the motor short-duration response (SDR) during a levodopa challenge in bilaterally STN-stimulated patients. Twenty-eight consecutive patients with a mean duration of Parkinson's disease of 16.6 +/- 6.0 years at the time of surgery were enrolled. Fourteen patients were evaluated both before STN stimulation and 3 months after surgery (group 1) whereas the other 14 patients were assessed before implantation and after a mean of 3 years of STN stimulation (group 2). After drug withdrawal for one night, the hand-tapping test (TT) was carried out every 15 min, together with evaluation of dyskinesias using a modified Goetz scale. The Unified Parkinson's Disease Rating Scale (UPDRS) motor score was assessed every 30 min. In operated patients, STN stimulation was stopped 15 min before starting the clinical evaluations. A suprathreshold oral levodopa dose was given after one motor evaluation and two TTs. The clinical evaluation was carried out until the TT score returned to the baseline. In group 1, six patients continued without levodopa after surgery and the other eight received a daily mean dose of 337 mg; in group 2, seven patients continued without levodopa and the other seven received a daily mean dose of 386 mg. The main change in the levodopa SDR was a significant reduction in levodopa-induced dyskinesias in both groups. In those patients of group 1 who did not receive levodopa after surgery, the motor UPDRS magnitude decreased and the 'on' UPDRS motor score worsened. In group 2, the results were similar, but in the patients who continued to receive levodopa after surgery the TT magnitude increased. On the whole, chronic bilateral STN stimulation tended to decrease the magnitude of the levodopa SDR without changing the duration and latency of the response. These results suggest that continuous STN stimulation induces long-term plastic changes of the dopaminergic system, with slow and partial desensitization. In addition, the persistence of levodopa intake after surgery might hinder this beneficial process.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12390968     DOI: 10.1093/brain/awf249

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  8 in total

1.  Effects of subthalamic nucleus stimulation on motor cortex plasticity in Parkinson disease.

Authors:  Sang Jin Kim; Kaviraja Udupa; Zhen Ni; Elena Moro; Carolyn Gunraj; Filomena Mazzella; Andres M Lozano; Mojgan Hodaie; Anthony E Lang; Robert Chen
Journal:  Neurology       Date:  2015-07-08       Impact factor: 9.910

Review 2.  Axial disability and deep brain stimulation in patients with Parkinson disease.

Authors:  Alfonso Fasano; Camila C Aquino; Joachim K Krauss; Christopher R Honey; Bastiaan R Bloem
Journal:  Nat Rev Neurol       Date:  2015-01-13       Impact factor: 42.937

3.  Longitudinal medication profile and cost savings in Parkinson's disease patients after bilateral subthalamic nucleus deep brain stimulation.

Authors:  Jing Han Ng; Angela An Qi See; Zheyu Xu; Nicolas Kon Kam King
Journal:  J Neurol       Date:  2020-05-04       Impact factor: 4.849

Review 4.  Disease-specific longevity of impulse generators in deep brain stimulation and review of the literature.

Authors:  Christoph van Riesen; Georg Tsironis; Doreen Gruber; Fabian Klostermann; Patricia Krause; Gerd Helge Schneider; Andreas Kupsch
Journal:  J Neural Transm (Vienna)       Date:  2016-05-19       Impact factor: 3.575

5.  Deep brain stimulation for the treatment of Parkinson's disease: efficacy and safety.

Authors:  Nader Pouratian; Sandeep Thakkar; Won Kim; Jeff M Bronstein
Journal:  Degener Neurol Neuromuscul Dis       Date:  2012-09-04

6.  Axial impairment and falls in Parkinson's disease: 15 years of subthalamic deep brain stimulation.

Authors:  Alessandro Zampogna; Francesco Cavallieri; Francesco Bove; Antonio Suppa; Anna Castrioto; Sara Meoni; Pierre Pélissier; Emmanuelle Schmitt; Amélie Bichon; Eugénie Lhommée; Andrea Kistner; Stephan Chabardès; Eric Seigneuret; Valerie Fraix; Elena Moro
Journal:  NPJ Parkinsons Dis       Date:  2022-09-24

7.  Subthalamic nucleus deep brain stimulation for Parkinson's disease: 8 years of follow-up.

Authors:  Dianyou Li; Chunyan Cao; Jing Zhang; Shikun Zhan; Shengdi Chen; Bomin Sun
Journal:  Transl Neurodegener       Date:  2013-05-24       Impact factor: 8.014

8.  Natural history of motor symptoms in Parkinson's disease and the long-duration response to levodopa.

Authors:  Roberto Cilia; Emanuele Cereda; Albert Akpalu; Fred Stephen Sarfo; Momodou Cham; Ruth Laryea; Vida Obese; Kenneth Oppon; Francesca Del Sorbo; Salvatore Bonvegna; Anna Lena Zecchinelli; Gianni Pezzoli
Journal:  Brain       Date:  2020-08-01       Impact factor: 13.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.